Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease

BACKGROUND: Increased platelet aggregation during antiplatelet therapy may predict cardiovascular events in patients with coronary artery disease. The majority of these patients receive aspirin monotherapy. We aimed to investigate whether high platelet‐aggregation levels predict cardiovascular event...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Sanne Bøjet, Grove, Erik Lerkevang, Neergaard‐Petersen, Søs, Würtz, Morten, Hvas, Anne‐Mette, Kristensen, Steen Dalby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586446/
https://www.ncbi.nlm.nih.gov/pubmed/28780510
http://dx.doi.org/10.1161/JAHA.117.006050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586446/
https://www.ncbi.nlm.nih.gov/pubmed/28780510
http://dx.doi.org/10.1161/JAHA.117.006050

Ejemplares similares